Ruilian Chen

678 total citations
29 papers, 509 citations indexed

About

Ruilian Chen is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ruilian Chen has authored 29 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Ruilian Chen's work include Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Cancer Genomics and Diagnostics (3 papers). Ruilian Chen is often cited by papers focused on Lung Cancer Treatments and Mutations (9 papers), Lung Cancer Diagnosis and Treatment (3 papers) and Cancer Genomics and Diagnostics (3 papers). Ruilian Chen collaborates with scholars based in China, Iran and Slovakia. Ruilian Chen's co-authors include Xudong Chen, Wei Hong, Guojian Chen, Xu‐Chao Zhang, Xiaofeng Lin, Yi‐Long Wu, Qing Zhou, Hai‐Yan Tu, Jin‐Ji Yang and Jian Su and has published in prestigious journals such as Journal of Clinical Oncology, Advanced Functional Materials and ACS Applied Materials & Interfaces.

In The Last Decade

Ruilian Chen

28 papers receiving 503 citations

Peers

Ruilian Chen
Ruilian Chen
Citations per year, relative to Ruilian Chen Ruilian Chen (= 1×) peers Xupeng Yang

Countries citing papers authored by Ruilian Chen

Since Specialization
Citations

This map shows the geographic impact of Ruilian Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruilian Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruilian Chen more than expected).

Fields of papers citing papers by Ruilian Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruilian Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruilian Chen. The network helps show where Ruilian Chen may publish in the future.

Co-authorship network of co-authors of Ruilian Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Ruilian Chen. A scholar is included among the top collaborators of Ruilian Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruilian Chen. Ruilian Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Hanhan, Ruilian Chen, Wei Guo, et al.. (2025). Immunotherapy as a neoadjuvant preoperative treatment for locally advanced pulmonary sarcomatoid carcinoma: a case report of clinical efficacy. Frontiers in Oncology. 15. 1483766–1483766.
3.
Lin, Xiaofeng, Yuqi Tang, Ruilian Chen, et al.. (2024). Physical Unclonable Functions with Hyperspectral Imaging System for Ultrafast Storage and Authentication Enabled by Random Structural Color Domains. Advanced Science. 11(31). e2401983–e2401983. 19 indexed citations
4.
Fu, Rui, Ye Xiong, Feng Li, et al.. (2023). EP09.04-02 Preoperative Circulating Tumor DNA Status Predicts Pathological Response in Advanced Non-small Cell Lung Cancer. Journal of Thoracic Oncology. 18(11). S599–S599. 1 indexed citations
5.
Zhou, Jie, Ruilian Chen, Jianyu Wu, et al.. (2023). Portable Comestible-Liquid Quality Test Enabled by Stretchable and Reusable Ion-Detection Photonic Papers. ACS Applied Materials & Interfaces. 15(11). 14854–14864. 3 indexed citations
7.
Liu, Hailu, Ruilian Chen, Fayong Li, et al.. (2021). Preparation and properties of PBAT/PLA composites modified by PVA and cellulose nanocrystals. Journal of Applied Polymer Science. 139(2). 16 indexed citations
8.
Li, Yue, Baokun Liang, Jing Yang, et al.. (2021). Cellulose Nanocrystals as Template for Improving the Crystallinity of Two-Dimensional Covalent Organic Framework Films. Polymers. 13(10). 1561–1561. 20 indexed citations
9.
Chen, Ruilian, Lingling Sun, Yang Cao, et al.. (2021). Adjuvant EGFR-TKIs for Patients With Resected EGFR-Mutant Non-Small Cell Lung Cancer: A Meta-Analysis of 1,283 Patients. Frontiers in Oncology. 11. 629394–629394. 17 indexed citations
10.
Lin, Ruiting, et al.. (2021). Efficacy of Osimertinib in NSCLC Harboring Uncommon EGFR L861Q and Concurrent Mutations: Case Report and Literature Review. Frontiers in Oncology. 11. 731572–731572. 1 indexed citations
11.
Qing, Weixia, et al.. (2021). Indocyanine green loaded pH-responsive bortezomib supramolecular hydrogel for synergistic chemo-photothermal/photodynamic colorectal cancer therapy. Photodiagnosis and Photodynamic Therapy. 36. 102521–102521. 20 indexed citations
12.
Chen, Ruilian, et al.. (2021). Re‐Printable Chiral Photonic Paper with Invisible Patterns and Tunable Wettability. Advanced Functional Materials. 31(16). 95 indexed citations
13.
Li, Wenfeng, Jun‐Tao Lin, Hong‐Hong Yan, et al.. (2020). Predictive and Prognostic Potential of TP53 in Patients With Advanced Non–Small-Cell Lung Cancer Treated With EGFR-TKI: Analysis of a Phase III Randomized Clinical Trial (CTONG 0901). Clinical Lung Cancer. 22(2). 100–109.e3. 36 indexed citations
14.
Su, Shan, Zhong‐Yi Dong, Zhi Xie, et al.. (2018). Strong Programmed Death Ligand 1 Expression Predicts Poor Response and De Novo Resistance to EGFR Tyrosine Kinase Inhibitors Among NSCLC Patients With EGFR Mutation. Journal of Thoracic Oncology. 13(11). 1668–1675. 101 indexed citations
15.
Chen, Ruilian, Jun Zhao, Xu‐Chao Zhang, et al.. (2018). Crizotinib in advanced non-small-cell lung cancer with concomitant ALK rearrangement and c-Met overexpression. BMC Cancer. 18(1). 1171–1171. 24 indexed citations
16.
Liu, Wenli, Xiaona Wang, Ruilian Chen, et al.. (2016). Effect of age on the pharmacokinetics of polymorphic nimodipine in rats after oral administration. Acta Pharmaceutica Sinica B. 6(5). 468–474. 4 indexed citations
17.
Chen, Ruilian, et al.. (2016). A Comparative Study on Dissolution Enhancement of Acetaminophen by Cooling, Anti-solvent, and Solvent Evaporation Crystallization. AAPS PharmSciTech. 18(1). 224–230. 4 indexed citations
18.
Chen, Ruilian, Jin‐Ji Yang, Xu‐Chao Zhang, et al.. (2015). ROS1 rearrangement coexists with EGFR mutation in non-small-cell lung cancer.. Journal of Clinical Oncology. 33(15_suppl). e19003–e19003. 1 indexed citations
19.
Wan, Lei, Jian Liu, Yuan Wang, et al.. (2012). Effects of Xinfeng capsule on pulmonary function based on treg-mediated notch pathway in a rat model of adjuvant arthritis. Journal of Traditional Chinese Medicine. 32(3). 430–436. 8 indexed citations
20.
Liu, Jian, et al.. (2009). The research on the change and the correlation of red cell parameter,cytokines in Adjuvant Arthritis Rats. 12(2). 146–148. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026